Barclays PLC Poly Pid Ltd. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.92 - $6.25 $278,320 - $443,750	-71,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.52 - $8.42 $391,919 - $597,820	71,000 New	71,000 $408,000
Q3 2020 Nov 12, 2020	SELL	$11.0 - $17.33 $376,706 - $593,483	-34,246 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$18.03 - $19.0 $617,455 - $650,674	34,246 New	34,246 $618,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $69.6M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.